Ion Channel Targeted Mechanisms of Anti-arrhythmic Chinese Herbal Medicine Xin Su Ning

Frontiers in Pharmacology
Taiyi WangYu-Ling Ma

Abstract

Xin Su Ning (XSN) is a China patented and certified herbal medicine used to treat premature ventricular contractions (PVCs) since 2005. A recent completed clinical trial of 861 patients showed that XSN had similar PVC inhibition rate to the class I antiarrhythmic drug mexiletine, at 65.85% for XSN and 63.10% for mexiletine. We have previously reported that XSN prolongs action potential duration (APD) and suppresses action potential amplitude (APA) of the cardiac ventricular myocytes. In this report we aim to reveal the effect of XSN on the ionic channels that govern APD and APA, which would help to explain the cellular electrophysiological mechanism of XSN. Our main findings are: (1) On ECG recorded in isolated rat, in the presence of XSN the amplitude of R wave was significantly decreased and the amplitude of T wave was increased significantly; (2) XSN blocked hNaV1.5 channel stably transfected cell line in a dose-dependent manner with an IC50 of 0.18 ± 0.02 g/L; and (3) XSN suppresses hERG channels in a dose-dependent manner with an IC50 of 0.34 ± 0.01 g/L. In conclusion, the clinical antiarrhythmic efficacy of XSN is based on its class I and Class III antiarrhythmic properties by suppression hNaV1.5 channel and hERG channels...Continue Reading

References

Nov 14, 1977·Biochimica Et Biophysica Acta·L M Hondeghem, B G Katzung
Nov 1, 1992·Journal of Clinical Pharmacology·E M Vaughan Williams
Jan 15, 1988·The American Journal of Cardiology·M R Rosen
Apr 1, 1984·Journal of the American College of Cardiology·D P ZipesJ J Heger
Jun 9, 2006·Journal of Biomolecular Screening·Alan FinkelJames Costantin
Aug 1, 2006·European Journal of Pharmacology·Yu-ling MaAlison M Gurney
Feb 1, 2008·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Yumiko KaneiPaul Schweitzer
Apr 3, 2009·The Journal of Physiological Sciences : JPS·Victor A MaltsevAlbertas Undrovinas
Mar 10, 2011·Journal of Molecular and Cellular Cardiology·Robert M BellDerek M Yellon
Jul 27, 2011·The Chinese Journal of Physiology·Shu-Lin LeeShyi-Wu Wang
Sep 3, 2011·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Alexander BurashnikovCharles Antzelevitch
Aug 10, 2012·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Jonathon C AdamsWin K Shen
Oct 26, 2013·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Li ZhongYong-Mei Cha
Jun 21, 2014·Journal of Cardiovascular Electrophysiology·Francesco SantoroAndrea Natale
Mar 15, 2015·Journal of Molecular and Cellular Cardiology·James N WeissZhilin Qu
Jul 22, 2015·Nature Reviews. Cardiology·Gerrit Frommeyer, Lars Eckardt
Jan 23, 2016·Science China. Life Sciences·Yingying SunKeji Chen
May 4, 2016·Molecular Pharmacology·Franck PotetAlfred L George
Nov 25, 2016·Drug Design, Development and Therapy·Xiaoyi WangWentao Zhu
Jan 5, 2017·Circulation Research·Brian O'RourkeD Brian Foster
Mar 13, 2018·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Rui GuoHongjun Yang

❮ Previous
Next ❯

Software Mentioned

Origin

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.